Product
Supplier
Encyclopedia
Inquiry
Home > Pharmaceutical Intermediates > Respiratory Tract (Find 51 items)

Respiratory Tract

Discover a wide selection of Respiratory Tract Pharma Intermediates for pharmaceutical research and production. Access raw materials with detailed CAS numbers, property data, and SDS to support the development of drugs for respiratory conditions, including asthma, COPD, and infections. Source high-quality intermediates from certified suppliers for reliable and safe usage.

L-(+)-Cysteine

(52-90-4)
Bread improver; nutritional supplement; antioxidant; color protectant. It has detoxification effect on acrylonitrile and aromatic acidosis; it has the effect of preventing radiation damage; it has the effect of treating bronchitis and phlegm; it has the effect of absorbing alcohol and converting it into acetaldehyde in the body. In biochemical research, it is used as an antidote for hepatitis, liver poisoning, radiopharmaceutical poisoning, antimony poisoning, etc. in medicine.

Product List

Request for quotation , get quotes from more suppliers.

Product List

Request for quotation , get quotes from more suppliers.

Mannitol

(69-65-8)
inhibitor of norepinephrine and seritonin uptake, treatment of fibromyalgia Labelled D-Mannitol (M165000). D-Mannitol is widespread in plants and plant exudates; obtained from manna and seaweeds. D-Mannitol is used in the food industry as anticaking and free-flow agent, flavo ring agent, lubricant and release agent, stabilizer and thickener and nutritive sweetener. Used in titrimetric determination of boric acid. Used with boric acid in the manufacture of dry electrolytic condensers for radio a

Product List

Request for quotation , get quotes from more suppliers.

L-(+)-Cysteine hydrochloride

(52-89-1)
A nonessential amino acid in humans. Important in protein crosslinking.

Product List

Request for quotation , get quotes from more suppliers.

Methanesulfonamide

(3144-09-0)
Methanesulfonamide is used in biological studies to predict binding affinity and binding mode of protein ligand complexes.

Product List

Request for quotation , get quotes from more suppliers.

Fmoc-leucine

(35661-60-0)
white to light yellow crystal powde

Product List

Request for quotation , get quotes from more suppliers.

Protocatechuic acid

(99-50-3)
A phenolic acid antioxidant and chemopreventive agent

Product List

Request for quotation , get quotes from more suppliers.

Fmoc-Lys(Boc)-OH

(71989-26-9)
white to light yellow crystal powde

Product List

Request for quotation , get quotes from more suppliers.

2-Chloro-4-nitroimidazole

(57531-37-0)
4-Nitroimidazole derivative with poetenial use as radiosensitizers of hypoxic cells.It is used in the preparation of antitubercular nitroimidazoles.

Product List

Request for quotation , get quotes from more suppliers.

Glycinamide hydrochloride

(1668-10-6)
The product is cyclized with glyoxal to obtain 2-hydroxypyrazine and then chlorinated with phosphorus oxychloride to prepare 23-dichloropyrazine for the production of sulfonamide SMPZ. Used as pharmaceutical intermediates for organic synthesis

Product List

Request for quotation , get quotes from more suppliers.

Respiratory tract drug intermediates are some key chemical raw materials or products in the synthesis process of respiratory tract drugs. You can easily find high-quality new intermediates, products and their manufacturers or suppliers on ECHEMI. We will always track the research and development of new products on respiratory system.

More Information

Respiratory Tract Pharma Intermediates are key raw materials used in the synthesis of pharmaceuticals targeting the respiratory system. These intermediates provide the foundation for bronchodilators, anti-inflammatory agents, antitussives, mucolytics, and antimicrobial therapies.

Common applications and types include:
• Bronchodilator intermediates — for asthma and COPD treatment.
• Anti-inflammatory intermediates — supporting therapies to reduce airway inflammation.
• Antitussive intermediates — for cough suppression and relief of upper respiratory symptoms.
• Mucolytic intermediates — aiding in the clearance of mucus and respiratory secretions.
• Antimicrobial intermediates — used in treatments for bacterial or viral respiratory infections.

Frequently Asked Questions

What is the respiratory tract and what are its main functions?

The respiratory tract is a series of organs and tissues involved in breathing and gas exchange. It includes the nose, pharynx, larynx, trachea, bronchi, and lungs. Its primary functions are to deliver oxygen to the bloodstream and remove carbon dioxide from the body. The respiratory tract also filters, warms, and humidifies inhaled air to protect lung tissue.

What are common diseases that affect the respiratory tract?

Common respiratory tract diseases include asthma, chronic obstructive pulmonary disease (COPD), bronchitis, pneumonia, sinusitis, and the common cold. These conditions can affect either the upper respiratory tract (nose, sinuses, throat) or the lower respiratory tract (trachea, bronchi, lungs). Symptoms often include coughing, shortness of breath, wheezing, and congestion.

How can I protect my respiratory tract from infections and pollutants?

To protect your respiratory tract, avoid smoking and exposure to secondhand smoke, wear masks in polluted or high-risk environments, practice good hand hygiene, stay up to date with vaccinations (such as flu and pneumococcal vaccines), and maintain indoor air quality with proper ventilation and air purifiers. Regular exercise and a healthy diet also support respiratory immunity.

What is the difference between upper and lower respiratory tract infections?

Upper respiratory tract infections (URTIs) involve the nose, sinuses, pharynx, and larynx, and include conditions like the common cold, sinusitis, and pharyngitis. Lower respiratory tract infections (LRTIs) affect the trachea, bronchi, and lungs, and include bronchitis, pneumonia, and tuberculosis. LRTIs are generally more severe and may require medical intervention compared to most URTIs.

When should I see a doctor for respiratory tract symptoms?

You should consult a healthcare provider if you experience persistent symptoms such as a cough lasting more than 2–3 weeks, high fever, difficulty breathing, chest pain, coughing up blood, or worsening shortness of breath. These could indicate a serious condition like pneumonia, COPD exacerbation, or other lower respiratory tract disorders requiring prompt evaluation and treatment.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.